Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Hodgkin Disease. Center for Cell and Gene Therapy,Baylor College of Medicine,Houston,Texas